BNR today
$13.24+$0.57 (+4.50%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bullish
15 minBullish
5 minConsolidating
Daily trend turns up above $22.50
Key levels
Resistance$16.36
Resistance$13.42
Support$9.98
Support$8.40
Latest news & SEC filings
GuidanceBrenntag sets out fresh plan and medium-term goals at investor event
EarningsBrenntag SE Posts Its Third-Quarter 2026 Numbers
DealBrenntag signs exclusive distribution deal with Graphene Manufacturing Group
All BNR news →About Burning Rock Biotech
Burning Rock Biotech is a China-based cancer diagnostics company that develops and commercializes next-generation sequencing (NGS) tests. Its products include tissue and liquid biopsy assays for therapy selection, as well as molecular residual disease (MRD) monitoring. The company serves hospitals, physicians, and patients in China, with operations conducted through subsidiaries and a variable interest entity.
Based on the company's 20-F filed Apr 28, 2026.
Nasdaq · Healthcare
Burning Rock Biotech Ltd (BNR)
What Is the Price Target for BNR?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is BNR a Buy or Sell Right Now?
Thesis
- •Revenue growing 1.8% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BNR.
Start Free Trial →Is BNR Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B
Fair Value
$16.00
40
Moat Score
NARROW
4/9
Piotroski Score
-5.5
Altman Z-Score
What Is Smart Money Doing with BNR?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BNR Growth Story
Revenue YoY
1.8%
3yr Revenue CAGR
-2.3%
EPS Growth YoY
-47.31%
FCF Growth YoY
63.0%
Revenue Trend
ACCELERATING
Dark Pool Trades for BNR
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BNR, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:15:22 | $13.10 | 1,000 | $$13K | BUY |
| 20:59:10 | $13.19 | 1,000 | $$13K | SELL |
| 17:42:17 | $12.87 | 2,795 | $$36K | SELL |
| 16:11:47 | $13.20 | 1,000 | $$13K | BUY |
| 13:51:29 | $10.80 | 1,000 | $$11K | BUY |
5 dark pool trades shown · $$86K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Burning Rock Biotech Ltd (BNR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BNR — frequently asked questions
What is BNR stock price today?
Burning Rock Biotech Ltd (BNR) is at $13.24, up 4.50% (+$0.57) at the Nov 11, 2026 close.
Why is BNR stock moving today?
Latest BNR news — Nov 12, 2026: Brenntag sets out fresh plan and medium-term goals at investor event · Nov 11, 2026: Brenntag SE Posts Its Third-Quarter 2026 Numbers
Did BNR beat earnings?
BNR last reported on Sep 10, 2026: EPS -$0.20 vs -$2.29 expected — a beat of 91.3%.
Does BNR pay a dividend?
BNR does not currently pay a dividend.
How much debt does BNR have?
Burning Rock Biotech Ltd reported $52M of debt and $520M of cash (Dec 31, 2024).
What are BNR support and resistance levels?
Support: $9.98, $8.40, $6.79. Resistance: $13.42, $16.36, $19.60.
What are insiders doing with BNR?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on BNR?
Nov 12, 2026: Brenntag sets out fresh plan and medium-term goals at investor event · Nov 11, 2026: Brenntag SE Posts Its Third-Quarter 2026 Numbers · Nov 4, 2026: Brenntag signs exclusive distribution deal with Graphene Manufacturing Group